Eris Pharmaceuticals Limited
About Eris Pharmaceuticals Limited
Data last updated:
Eris Pharmaceuticals Limited is a public limited company based in Fatehpur Roshnai, Uttar Pradesh, India, a subsidiary of Eris Healthcare Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U33100UP2020PLC128964. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Inderjeet Singh Negi and Kaushal Kamlesh Shah.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Fatehpur Roshnai, Uttar Pradesh.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Eris Pharmaceuticals has one previous CIN (Corporate Identification Number): U33100UP2020PTC128964. The current CIN is U33100UP2020PLC128964, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U33100UP2020PLC128964 | Current |
| U33100UP2020PTC128964 | Previous |
Contact details
Eris Pharmaceuticals Limited's registered office is in Fatehpur Roshnai, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressArazi No. 1554, Vill Sachendi Kalpi Road, Fatehpur Roshnai, Uttar Pradesh, India – 209304
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Eris Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Eris Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Eris Pharmaceuticals Limited, buy the company report.
Financials of Eris Pharmaceuticals Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Eris Pharmaceuticals Limited, buy the company report.
Board of directors of Eris Pharmaceuticals Limited
Eris Pharmaceuticals has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Inderjeet Singh Negi Also directs: Eris Lifesciences Limited, Eris Healthcare Private Limited, Eris Therapeutics Limited and 3 more | Director | 30 Jul 2024 | 2 Years 2 Months | Current |
| Kaushal Kamlesh Shah Also directs: Eris Lifesciences Limited, Eris Healthcare Private Limited, Eris Therapeutics Limited and 5 more | Director | 30 Jul 2024 | 2 Years 2 Months | Current |
| Sachin Shah Also directs: Eris Healthcare Private Limited, Eris Therapeutics Limited, Aprica Healthcare Limited and 4 more | Director | 30 Jul 2024 | 2 Years 2 Months | Current |
Auditor
Eris Pharmaceuticals Limited is audited by RRS & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RRS & Associates | FY 2023 | 118336W |
Shareholding
The shareholding of Eris Pharmaceuticals Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Eris Pharmaceuticals Limited, buy the company report.
Legal cases
No court or tribunal cases involving Eris Pharmaceuticals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eris Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Eris Pharmaceuticals Limited has 1 active EPFO establishment as of Apr 04, 2024.
GST
Eris Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Eris Pharmaceuticals Limited, buy the company report.
Recent activity
Eris Pharmaceuticals Limited has 9 board changes on record since 2024: 3 appointments and 6 cessations. The latest: Inderjeet Singh Negi ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Eris Pharmaceuticals is an active public limited company based in Fatehpur Roshnai, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 June 2020 (6+ years old) and is registered under CIN U33100UP2020PLC128964.
Eris Pharmaceuticals has 3 current directors:
- Inderjeet Singh Negi - Director
- Kaushal Kamlesh Shah - Director
- Sachin Shah - Director
The latest financial statements of Eris Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
No. Eris Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Eris Pharmaceuticals is U33100UP2020PLC128964. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eris Pharmaceuticals was incorporated on 02 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kanpur.
Inderjeet Singh Negi ceased to be Additional Director on 29 Sep 2024. Kaushal Kamlesh Shah ceased to be Additional Director on 29 Sep 2024. Sachin Shah ceased to be Additional Director on 29 Sep 2024. Eris Pharmaceuticals has 9 board changes on record in total.
The registered office of Eris Pharmaceuticals is at Arazi No. 1554, Vill Sachendi Kalpi Road, Fatehpur Roshnai, Uttar Pradesh, India – 209304.
Eris Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Eris Pharmaceuticals is compliant as of 11 July 2026. The company is actively filing with the Registrar of Companies.